Type 2 diabetes susceptibility gene GRK5 regulates physiological pancreatic β-cell proliferation via phosphorylation

Shugo Sasaki1,2, Cuilan Nian1,2,3, Eric E Xu1,3

  • 1BC Children's Hospital Research Institute, Vancouver, BC, Canada.

Iscience
|July 31, 2023
PubMed

Insights

This study reveals that GRK5 is crucial for maintaining beta cell mass and function, impacting glucose tolerance. Targeting GRK5 may offer a new therapeutic strategy for type 2 diabetes (T2D) by preserving beta cells.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Diabetes Research

Background:

  • Restoring functional beta cell mass is a key therapeutic goal for diabetes.
  • Understanding the pathways that regulate beta cell mass is essential for developing effective treatments.
  • Previous work identified Sox4 as critical for beta cell proliferation in prediabetes.

Purpose of the Study:

  • To investigate the role of Sox4 in regulating beta cell mass.
  • To elucidate the connection between Sox4, GRK5, and beta cell mass.
  • To explore GRK5 as a potential therapeutic target for type 2 diabetes (T2D).

Main Methods:

  • Examined the effect of Sox4 on GRK5 expression in beta cells.
  • Generated beta cell-specific Grk5 knockout mice.
  • Assessed glucose tolerance and beta cell mass in knockout mice.
  • Investigated the downstream signaling pathway of GRK5, including HDAC5 phosphorylation and immediate-early gene (IEG) expression.

Main Results:

  • Sox4 regulates beta cell mass by modulating the expression of the T2D susceptibility gene GRK5.
  • Beta cell-specific Grk5 knockout mice exhibited impaired glucose tolerance and reduced beta cell mass.
  • Reduced beta cell mass in knockout mice was associated with increased expression of the cell cycle inhibitor gene Cdkn1a.
  • GRK5 appears to promote beta cell proliferation via a pathway involving HDAC5 phosphorylation and subsequent transcription of IEGs like Nr4a1, Fosb, Junb, Arc, Egr1, and Srf.

Conclusions:

  • GRK5 plays a significant role in regulating beta cell growth and is linked to T2D pathogenesis.
  • GRK5 may serve as a therapeutic target for preserving beta cell function and mass during T2D development.

Related Concept Videos

Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.6K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.3K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
3.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.7K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
993
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K